483 Xellia Pharmaceuticals USA Oct 2019

483 Xellia Pharmaceuticals USA Oct 2019

Marla Cassidy FDA, Jacqueline Diaz Albert FDA$595.00 - Available Now

FDA investigators audited the Xellia Pharmaceuticals USA - Raleigh, NC, United States facility and issued inspectional observations (via FDA 483) on 18 Oct 2019.

Product details

  • Category: Biologics
  • Inspection end: 18 Oct 2019
  • Location: Raleigh, United States
  • FEI: 3005208599
Add To Cart